Benzinga | Sep 17, 2020 08:27AM EDT

Avadel To Present At Oppenheimer Fall Healthcare Life Sciences & MedTech Summit Sept. 22

DUBLIN, Ireland, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc(NASDAQ:AVDL) a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate, today announced that its executive team will be presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit taking place September 21 -- 23, 2020.



Presentation details:Date: Tuesday, September 22, 2020Time: 10:50 a.m. ? 11:30 a.m. ETWebcast: A live and archived webcast of the presentation will be available at ( click here) or on the Company's website (click here)

In addition, management will be participating in one-on-one meetings with investors who are registered to attend the conference.